News imminent, but not in the next few days.
From today's article:
"Further analysis of the study results are expected in a few weeks, which will inform the company on the path forward and potential clinical study design for diabetic kidney disease."
Also:
Remap-cap Covid-19 news expected this month.
Load up, page-24
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.8¢ |
Change
0.003(0.68%) |
Mkt cap ! $203.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.8¢ | $21.14K | 57.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 127920 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 29127 | 3 |
View Market Depth
| Last trade - 10.10am 02/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |